Abstract |
Enhanced external counterpulsation (EECP) was used to treat 30 patients with refractory angina due to cardiac Syndrome X, with an initial improvement in CCS angina class (3.57 to 1.43; p<0.001) and regional ischemia in all treated patients. At a mean of 11.9 months follow-up, 87% of patients had sustained improvement in angina and were without MACE. EECP, by improving endothelial function, may be an effective and durable treatment for this often difficult to treat problem.
|
Authors | Kenneth D Kronhaus, William E Lawson |
Journal | International journal of cardiology
(Int J Cardiol)
Vol. 135
Issue 2
Pg. 256-7
(Jun 26 2009)
ISSN: 1874-1754 [Electronic] Netherlands |
PMID | 18590931
(Publication Type: Clinical Trial, Letter)
|
Topics |
- Aged
- Counterpulsation
- Female
- Humans
- Male
- Microvascular Angina
(surgery)
- Middle Aged
- Treatment Outcome
|